Dees Illustration |
Activist Post
The swine flu pandemic of 2009 was caused by a type A influenza (H1N1) virus. This virus was originally referred to as "swine flu" because many of the genes of this new virus were very similar to influenza viruses that normally occur in pigs in North America. The H1N1 virus is genetically similar to the 1918 pandemic virus, as determined from victims of the latter who were buried, and later disinterred, in Svalbard. It was responsible for most of the outbreaks up until 1956 and then disappeared.
However, this new virus was actually quite different from the typical swine flu viruses. This virus first caused illness in Mexico and the United States in March and April, 2009. This novel H1N1 flu spread from person to person, unlike typical swine flu. In 2009 vaccines were being developed for the prevention of swine flu in humans. (Source)
On 11 June 2009, the World Health Organization (WHO) declared that the swine flu had developed into a full-scale world epidemic -- a pandemic alert to Phase 6. Margaret Chan, the Director-General of WHO, commented on the situation in a somewhat ambiguous way. While stressing that the swine flu had reached a serious pandemic level, she declared later in the same statement that the illness seemed to be mild and that most of the patients would recover without medical intervention. (Source)
The world chose to listen to the first part of her message.
On 11 June 2009, the World Health Organization (WHO) declared that the swine flu had developed into a full-scale world epidemic -- a pandemic alert to Phase 6. Margaret Chan, the Director-General of WHO, commented on the situation in a somewhat ambiguous way. While stressing that the swine flu had reached a serious pandemic level, she declared later in the same statement that the illness seemed to be mild and that most of the patients would recover without medical intervention. (Source)
The world chose to listen to the first part of her message.
Two pharmaceutical companies GlaxoSmithKline (GSK) and Novartis had, under considerable time pressure, developed a vaccine against the swine flu. Since the cultivation of an adequate amount of virus to generate the vaccine requires time, GSK and Novartis decided to formulate a weaker vaccine but strengthen it with an adjuvant that contains squalene. Immunologic adjuvants are substances, administered in conjunction with a vaccine, that stimulate the immune system and increase the response to the vaccine. (Source)
http://www.activistpost.com/2012/03/health-authorities-now-admit-se...
You need to be a member of 12160 Social Network to add comments!
Join 12160 Social Network